Supernus Pharmaceuticals | SUPN - Current Assets



Supernus Pharmaceuticals reported $738.87M in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Abbott USD 24.47B 1.32B Jun/2025
ANI Pharmaceuticals USD 602.63M 66.34M Jun/2025
Aurora Cannabis CAD 465.3M 28.91M Jun/2025
Bristol-Myers Squibb USD 33.22B 2.44B Jun/2025
Canopy Growth CAD 303.36M 37.72M Jun/2025
Corcept Therapeutics USD 443.11M 4.61M Jun/2025
Eisai JPY 763.15B 35.49B Jun/2025
Eli Lilly USD 49.85B 8.59B Jun/2025
Novo Nordisk 162.71B 11.69B Jun/2025
Pacira USD 745.61M 14.35M Jun/2025
Perrigo USD 2.62B 82M Jun/2025
Pfizer USD 43.7B 2.16B Jun/2025
Supernus Pharmaceuticals USD 738.87M 51.28M Jun/2025
United Therapeutics USD 3.83B 112.9M Jun/2025
Xeris Pharmaceuticals USD 185.58M 17.92M Jun/2025